These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28007131)

  • 1. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Levitz L
    J Cataract Refract Surg; 2016 Dec; 42(12):1852. PubMed ID: 28007131
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome.
    Coassin M; Iovieno A; Soldani A; Cavuto S; Cimino L; Sartori A; Formisano D; Fontana L
    J Cataract Refract Surg; 2016 Aug; 42(8):1119-25. PubMed ID: 27531286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromfenac Ophthalmic Solution 0.07%: A Review of Its Use After Cataract Surgery.
    Hoy SM
    Clin Drug Investig; 2015 Aug; 35(8):525-9. PubMed ID: 26177719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.
    Walters TR; Goldberg DF; Peace JH; Gow JA;
    Ophthalmology; 2014 Jan; 121(1):25-33. PubMed ID: 24021896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Miyanaga M; Miyai T; Nejima R; Maruyama Y; Miyata K; Kato S
    Acta Ophthalmol; 2009 May; 87(3):300-5. PubMed ID: 19183412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
    Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain.
    Silverstein SM; Cable MG; Sadri E; Peace JH; Fong R; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Curr Med Res Opin; 2011 Sep; 27(9):1693-703. PubMed ID: 21751945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent.
    Jones J; Francis P
    Expert Opin Pharmacother; 2009 Oct; 10(14):2379-85. PubMed ID: 19735215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
    Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
    Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute corneal melt associated with topical bromfenac use.
    Prasher P
    Eye Contact Lens; 2012 Jul; 38(4):260-2. PubMed ID: 22169877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery.
    Wentz SM; Price F; Harris A; Siesky B; Ciulla T
    Expert Opin Pharmacother; 2019 Oct; 20(14):1703-1709. PubMed ID: 31343372
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor.
    Miyake K; Ogawa T; Tajika T; Gow JA; McNamara TR
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):573-8. PubMed ID: 19049295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
    Donnenfeld ED; Donnenfeld A
    Int Ophthalmol Clin; 2006; 46(4):21-40. PubMed ID: 17060789
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and safety of sodium bromfenac eye drops in the treatment of postoperative inflammation in cataract surgery: A protocol for systematic review and meta-analysis.
    Wang C; Cao Y; Chen X; Cai M; Huang W
    Medicine (Baltimore); 2020 Dec; 99(49):e23131. PubMed ID: 33285687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.
    Macrì A; Vagge A; Salis A; Fucile C; Marini V; Martelli A; Giuffrida S; Iester M; Damonte G; Mattioli F
    Int Ophthalmol; 2017 Apr; 37(2):417-421. PubMed ID: 27324371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes.
    Endo N; Kato S; Haruyama K; Shoji M; Kitano S
    Acta Ophthalmol; 2010 Dec; 88(8):896-900. PubMed ID: 19725815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The systemic safety of bromfenac ophthalmic solution 0.09%.
    Stewart RH; Grillone LR; Shiffman ML; Donnenfeld ED; Gow JA;
    J Ocul Pharmacol Ther; 2007 Dec; 23(6):601-12. PubMed ID: 18001250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.